|
Title
|
|
* ! Statistics in Brain Mapping
|
|
Date / Time / Room
|
Sponsor
|
Type
|
08/15/2002
8:30 AM -
10:30 AM
Room: S-Royal Ballroom B
|
Biometrics Section*, Biopharmaceutical Section*, ENAR, Section on Statistical Graphics*
|
Invited
|
|
Organizer:
|
Thomas E. Bradstreet, Merck Research Laboratories
|
|
Chair:
|
Thomas E. Bradstreet, Merck Research Laboratories
|
|
Discussant:
|
|
|
Floor Discussion
|
10:15 AM
|
Description
Brain mapping is a rapidly growing research field that tries to understand human brain function and anatomy using 3-D images from MRI, fMRI, PET, EEG, and MEG implementing geometry, topology, statistics, and random fields. Many pharmaceutical companies are spending enormous amounts of monies utilizing the emerging brain mapping technology as an integral part of their drug development procedures, particularly in evaluating receptor site activity and constructing dose response theories.
Brain mapping is a scientific area which by its very nature provides for collaboration between several scientific disciplines including statisticians, physicians, mathematicians, computer scientists, physicists, pharmacologists, and pharmacokineticists. Much collaborative work remains to be done in the quantitative summary and evaluation of brain mapping data. There does not appear to be any standard and universally accepted set of probabilistic or statistical evaluation criteria, and the mathematical and statistical methodologies continue to evolve.
|
|
